Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: Selected Presentations from the 29th Conference of the German Society for Clinical Hemorheolgy and Microcirculation, Freie Universität Berlin, Germany, 17–18 September 2010
Article type: Research Article
Authors: Mayer, A. | Lee, S. | Lendlein, A. | Jung, F. | Hiebl, B.
Affiliations: Berlin-Brandenburg Centre for Regenerative Therapies, Berlin, Germany and Centre for Biomaterial Development, Institute of Polymer Research, Helmholtz-Zentrum Geesthacht, Teltow, Germany
Note: [] Corresponding author: B. Hiebl, Berlin-Brandenburg Centre for Regenerative Therapies, Berlin, Germany and Centre for Biomaterial Development, Institute of Polymer Research, Helmholtz-Zentrum Geesthacht, Kantstr. 55, 14513 Teltow, Germany. Tel.: +49 3328 352 0; Fax: +49 3328 352 452; E-mail: [email protected]
Abstract: Cardiovascular implants such as stents or artificial vascular grafts established in clinical application to date are generally designed as long-term implants. An important requirement for the successful application of these devices is the haemocompatibility of their interface to the blood stream, which often is approached by polymeric coatings. Modern therapies are aiming at curative treatments (Regenerative Medicine) by inducing the in vivo formation of a new endothelial layer on the implant surface ensuring an optimal haemocompatibility based on the generated glycocalyx. A promising approach for providing the required biological stimulus is the secretion of pro-angiogenic factors (such as VEGF-A) by autologous CD14+ monocytes/macrophages (mo/mΦ), which can be induced by previous angiogenic stimulation. While protocols for negative and positive immune-isolation are already established, this study was aimed to evaluate the efficacy of a positive and a negative MACS™ based immune-isolation protocol by analysing the yield, the purity and the activation status of the isolated CD14+ mo/mΦ. Both protocols enabled the isolation of more than 80% (positive isolation) and 86% (negative isolation) CD14+ mo/mΦ representing approximately 1.3 × 107 CD14+ mo/mΦ from 1 ml buffy coat. Less than 10% of these cells were also positive for CD69. Latter is an important selection criterion as CD69 is a marker characteristic for classically activated and catabolic active mo/mΦ which can negatively affect the endothelialisation process. As the negative immune-isolation protocol resulted in a cell fraction meeting the requirements on a pure cell fraction (percentage of contaminating cells < 15%) this isolation method is advantageous although it was more time consuming than the positive isolation protocol.
Keywords: CD14 antigens, CD69 antigens, cell isolation techniques/methods, monocytes, macrophages, endothelialisation
DOI: 10.3233/CH-2011-1395
Journal: Clinical Hemorheology and Microcirculation, vol. 48, no. 1-3, pp. 57-63, 2011
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]